MXRA5 and familial pancreatic carcinoma: MXRA5 overexpression in pancreatic cancer was correlated with higher T classification (AUC = 0.659), N classification (AUC = 0.640) and clinical pathological stage (AUC = 0.712) (Fig. 1F, G).